252 related articles for article (PubMed ID: 31387668)
1. Transmissible Cancers and Immune Downregulation in Tasmanian Devil (
Chale RS; Ghiam N; McNamara SA; Jimenez JJ
Comp Med; 2019 Aug; 69(4):291-298. PubMed ID: 31387668
[TBL] [Abstract][Full Text] [Related]
2. A tale of two tumours: comparison of the immune escape strategies of contagious cancers.
Siddle HV; Kaufman J
Mol Immunol; 2013 Sep; 55(2):190-3. PubMed ID: 23200636
[TBL] [Abstract][Full Text] [Related]
3. Transmissible Tumors: Breaking the Cancer Paradigm.
Ostrander EA; Davis BW; Ostrander GK
Trends Genet; 2016 Jan; 32(1):1-15. PubMed ID: 26686413
[TBL] [Abstract][Full Text] [Related]
4. Clonally transmissible cancers in dogs and Tasmanian devils.
Murchison EP
Oncogene; 2008 Dec; 27 Suppl 2():S19-30. PubMed ID: 19956175
[TBL] [Abstract][Full Text] [Related]
5. Curse of the devil: molecular insights into the emergence of transmissible cancers in the Tasmanian devil (Sarcophilus harrisii).
Patchett AL; Flies AS; Lyons AB; Woods GM
Cell Mol Life Sci; 2020 Jul; 77(13):2507-2525. PubMed ID: 31900624
[TBL] [Abstract][Full Text] [Related]
6. Lessons learnt from the Tasmanian devil facial tumour regarding immune function in cancer.
Peel E; Belov K
Mamm Genome; 2018 Dec; 29(11-12):731-738. PubMed ID: 30225648
[TBL] [Abstract][Full Text] [Related]
7. Does the devil facial tumour produce immunosuppressive cytokines as an immune evasion strategy?
Morris K; Belov K
Vet Immunol Immunopathol; 2013 May; 153(1-2):159-64. PubMed ID: 23465357
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils.
Pye R; Hamede R; Siddle HV; Caldwell A; Knowles GW; Swift K; Kreiss A; Jones ME; Lyons AB; Woods GM
Biol Lett; 2016 Oct; 12(10):. PubMed ID: 28120799
[TBL] [Abstract][Full Text] [Related]
9. Immunology of naturally transmissible tumours.
Siddle HV; Kaufman J
Immunology; 2015 Jan; 144(1):11-20. PubMed ID: 25187312
[TBL] [Abstract][Full Text] [Related]
10. Evolution in a transmissible cancer: a study of the chromosomal changes in devil facial tumor (DFT) as it spreads through the wild Tasmanian devil population.
Pearse AM; Swift K; Hodson P; Hua B; McCallum H; Pyecroft S; Taylor R; Eldridge MD; Belov K
Cancer Genet; 2012 Mar; 205(3):101-12. PubMed ID: 22469509
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis and molecular biology of a transmissible tumor in the Tasmanian devil.
Bender HS; Marshall Graves JA; Deakin JE
Annu Rev Anim Biosci; 2014 Feb; 2():165-87. PubMed ID: 25384139
[TBL] [Abstract][Full Text] [Related]
12. Devil Facial Tumor Disease.
Pye RJ; Woods GM; Kreiss A
Vet Pathol; 2016 Jul; 53(4):726-36. PubMed ID: 26657222
[TBL] [Abstract][Full Text] [Related]
13. Mitogen-activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells.
Brown GK; Tovar C; Cooray AA; Kreiss A; Darby J; Murphy JM; Corcoran LM; Bettiol SS; Lyons AB; Woods GM
Immunol Cell Biol; 2016 Aug; 94(7):673-9. PubMed ID: 27089941
[TBL] [Abstract][Full Text] [Related]
14. Contagious cancer.
Welsh JS
Oncologist; 2011; 16(1):1-4. PubMed ID: 21212437
[TBL] [Abstract][Full Text] [Related]
15. Transmissible cancer influences immune gene expression in an endangered marsupial, the Tasmanian devil (Sarcophilus harrisii).
Raven N; Klaassen M; Madsen T; Thomas F; Hamede RK; Ujvari B
Mol Ecol; 2022 Apr; 31(8):2293-2311. PubMed ID: 35202488
[TBL] [Abstract][Full Text] [Related]
16. Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations.
Kreiss A; Brown GK; Tovar C; Lyons AB; Woods GM
Vaccine; 2015 Jun; 33(26):3016-25. PubMed ID: 25708088
[TBL] [Abstract][Full Text] [Related]
17. Transmissible cancer in Tasmanian devils: localized lineage replacement and host population response.
Hamede RK; Pearse AM; Swift K; Barmuta LA; Murchison EP; Jones ME
Proc Biol Sci; 2015 Sep; 282(1814):. PubMed ID: 26336167
[TBL] [Abstract][Full Text] [Related]
18. A comparative genomics approach to understanding transmissible cancer in Tasmanian devils.
Deakin JE; Belov K
Annu Rev Genomics Hum Genet; 2012; 13():207-22. PubMed ID: 22657390
[TBL] [Abstract][Full Text] [Related]
19. Immunology of a Transmissible Cancer Spreading among Tasmanian Devils.
Woods GM; Howson LJ; Brown GK; Tovar C; Kreiss A; Corcoran LM; Lyons AB
J Immunol; 2015 Jul; 195(1):23-9. PubMed ID: 26092814
[TBL] [Abstract][Full Text] [Related]
20. Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils.
Tovar C; Pye RJ; Kreiss A; Cheng Y; Brown GK; Darby J; Malley RC; Siddle HV; Skjødt K; Kaufman J; Silva A; Baz Morelli A; Papenfuss AT; Corcoran LM; Murphy JM; Pearse MJ; Belov K; Lyons AB; Woods GM
Sci Rep; 2017 Mar; 7():43827. PubMed ID: 28276463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
